A complex interaction between genetic factors and sex hormones underlies the differential susceptibility of genders to the analyzed neurodevelopmental disorders.

Drugs targeting sex hormones-related signaling pathways may represent promising therapeutic strategies for several neurodevelopmental disorders.

Further studies are needed for a better understanding of the mechanisms underlying risk and resilience to disease between the sexes.